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ABSTRACT 
In a year, Tuberculosis (TB) caused approximately a million deaths in addition to 10 million infection cases; 
thus, it has been subjected to intensive study with the goal of creating a novel therapeutic drug – specifically 
allosteric inhibitors. Mycobacterium tuberculosis, a pathogenic bacteria that causes TB, has an enzyme found in 
all organisms and is involved in essential metabolic reactions within the cell, known as Malate Dehydrogenase 
(MDH). Understanding the structure and function relationships in MDH as well as the specific steps of catalysis 
can assist in biotech purposes by designing a drug that can specifically bind to a region of pathogenic MDH. 
MDH catalyzes the reversible conversion of malate to oxaloacetate coupled with the concomitant co-factor 
conversion of NAD+ to NADH. It is regulated via allosteric inhibition by citrate and substrate inhibition by 
oxaloacetate. The homodimeric enzyme contains an active site and within this active site there is a mobile loop 
(P119-N137) that exhibits an opened conformation when substrate/co-factor is bound and a closed conformation 
when none is bound. Two out of the three catalytic Arg (R124 and R130) is within the loop and its charges play 
a role in positioning the substrate into the correct orientation for efficient catalysis. To further garner information 
about the loop, comparison to Lactate Dehydrogenase has been made since it is thought that LDH may have 
evolved from MDH, a step requiring altering substrate affinity for lactate/pyruvate. Previous studies mutated the 
catalytic Arg in MDH and revealed an altered substrate affinity to pyruvate rather than oxaloacetate – revealing 
the importance of the loop’s role in substrate specificity. To investigate a possible target within the loop that 
may render pathogenic bacteria MDH inactive without affecting host MDH, sequence and structural 
bioinformatics have been done to identify residues that are different in Mtb enzyme than the human 
mitochondrial and cytosolic forms. From sequence alignment of several forms of MDH and LDH, K125 was 
found to be conserved throughout except in LDH, halophiles and prokaryotic MDH. From HINT computational 
analyses, it was clear K125 made essential interactions with co-factor and nearby residues that may be involved 
in catalysis, binding and substrate specificity and several interactions not found in the analysis were predicted. 
It is hypothesized that the role of K125 may involve the positioning of R124 via charge repulsion and a stabilizing 
hydrogen bond with G263 to guide the substrate into the active site, thus completing the electrostatic pre-
organization required for catalysis. To investigate the specific role of K125 in binding, catalysis and specificity, 
we have constructed via Quikchange mutagenesis as well as expressed and purified via Ni-NTA affinity 
chromatography  two watermelon glyoxysomal MDH (wgMDH) mutants, K125A and K125R. The purified 
mutants were characterized via Michaelis-Menten enzyme kinetics to determine overall catalytic efficiency as 
well as substrate and co-factor binding compared to native wgMDH. Substrate inhibition assays were performed 
utilizing malonate, pyruvate and citrate to assess substrate specificity changes, if any, in the mutants. 
Fluorescence-based Thermal Shift Assays (FbTSA) were done to assess changes in stability and co-factor 
binding of the mutants. Kinetic studies revealed no significant changes in Km of NADH and OAA and changes 
in Vmax of NADH and OAA, suggesting K125 may not be involved in co-factor/substrate binding. Citrate 
inhibition kinetics indicated the loss of affinity for citrate in K125A and Malonate inhibition kinetics showed 
K125R had a slightly higher affinity for malonate compared to native and K125A. This indicates that K125 plays 
a role in substrate specificity. FbTSA analysis indicated an increase in structural stability for both K125A and 
K125R compared to native, suggesting it has a role in stability. Thus, it can be proposed from these results that 
K125 is essential for catalysis by playing a role in substrate specificity and interactions K125 makes with nearby 
residues are essential for structural stability of MDH. Overall, these results not only contributes to the gaps in 
knowledge in regards to structure-function relationships of essential enzymes, these findings may also be utilized 
for biotech purposes. The new discoveries made may provide further insight into potential residual targets within 
MDH for allosteric inhibitor drugs that can render pathogenic bacterial MDH inactive without the drug being 




Tuberculosis (TB) is one of the top 10 leading causes of death worldwide, making it a public 
health crisis1. Mycobacterium tuberculosis (Mtb) is the causative agent of TB. Mtb’s ability to 
survive in a fully functioning immune system in a prolonged latent state poses a great challenge 
to the host’s immune system to act against TB2. With the emergence of resistant strains of Mtb3, 
novel therapeutic intervention, such as allosteric inhibitor drugs, is needed. Targeting metabolic 
enzymes has been of interest with regards to antibiotics, but effective inhibitors have been 
challenging to design due to the conserved nature of proteins4. The solution lays in the details of 
understanding the structure and function relationships of metabolic enzymes and how non-
covalent interactions play a role in this relationship. An enzyme’s binding site structure contain 
clues as to how the enzyme achieves substrate specificity during catalysis. Insights into the 




Chemical reaction catalyzed by Malate Dehydrogenase.  
The oxidation and reduction of substrates and corresponding coordinating and catalytic residues 
within the active site pocket. Residue position numbering based on watermelon glyoxysomal MDH 
(1SEV). 
For aerobic organisms, the tricarboxylic acid (TCA) cycle is the converging point for numerous 
catabolic reactions5, which is an essential step in cellular metabolism. Malate dehydrogenase 
(MDH) is one of the enzymes involved in the TCA cycle that plays a role in catalyzing the 
reversible oxidation/reduction of substrates malate/oxaloacetate, coupled with cofactor 
conversion NAD+/NADH (Fig. 1). This enzyme is found in all organisms – plants, animals, 
bacteria as well as yeast6. Although the reaction in vivo goes in the forward direction of 
oxaloacetate/NADH, the equilibrium constant for the reaction favors the reverse direction, 
favoring malate/NAD+7. Previous studies have determined the reaction’s Keq at near 
physiological conditions (38 °C, pH 7) to be 2.86 ± 0.12 x 10-5 in the forward direction7. Two 
main forms of MDH present eukaryotes are mitochondrial MDH (mMDH)8 and cytoplasmic 







the tricarboxylic acid cycle in the mitochondrial matrix10. The first MDH structures crystallized 
were of pig cMDH11 and mMDH12. Another isoform, glyoxysomal MDH (gMDH), was found in 
yeast13 and plant14 glyoxysome and is involved in the conversion of malate produced from 
glyoxylate cycle. X-ray crystal structures indicated MDH to be a homodimer, containing two 
identical subunits with a 2-fold symmetry, as well as an interface between the subunits15 as seen 
in Fig. 2A. The NAD-binding domain comprises of a parallel β-sheet structure, also known as 
the Rossman fold motif16 (β−α−β−α−β−β−α−β−α−β), present in various enzymes that 
specifically binds NADH.  
A 




Malate Dehydrogenase Structure 
(A) Homodimeric structure of MDH. Active site loop is shown in light blue. Malate and NAD are 
shown in spheres. Active site pocket is shown in grey mesh, NADH in yellow and malate in pink. 
(B) Putty Representation of Flexible Loop Colored by B-Factor. The color range bar represents 
the B-factor scale from 0 (purple) to 8 (red) Å. Subunit C of wgMDH is shown in light grey mesh 
(PDB: 1SMK). 
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The active site is comprised of a binding pocket for substrate, oxaloacetate and malate, as well as 
a site for the nicotinamide ring of cofactor NADH17, a flexible loop, and essential conserved 
residues (Fig. 2A). A flexible loop (P119-N137) is present to assist with substrate binding17. In 
Figure 2A, the loop is in a closed conformation when substrates are bound.  
From x-ray crystal structures, it has been seen that the other subunit’s loop takes on an open 
conformation when one subunit’s loop is in a closed conformation. It is known as the “flexible 
loop” due to its high temperature factors18, also known as “b-factors” (Fig. 2B). As shown in Fig. 
2B, the loop region has an overall high b-factor value, which correlates to the excessive 
movement of atoms; hence, the term “flexible” has been associated with the loop region. It 
undergoes a conformational change during catalysis, where a bound substrate in the active site 
induces a closed conformation in one subunit, while the loop in the other subunit remains in an 
open conformation19. The kinetic parameters of watermelon glyoxysomal MDH (wgMDH) have 
been determined by previous studies20. At 0.5 and 5.0 mM oxaloacetate concentration, Km of 
gMDH for NADH is 146 µM20. The Km for oxaloacetate is 75.8 ± 6.7 µM at 50 µM NADH 
concentration and 147.6 ± 7.0 µM for 200 µM NADH concentration20. The Vmax20 determined 
was 9.2 x 102 min-1. A hallmark of MDH is it follows the ordered bi-bi mechanism, where 
cofactor NADH must bind first to the enzyme then to the substrate to make a ternary complex 
(E-NADH-Substrate) necessary for catalysis21.  
 
FIGURE 3 
Schematic of Conserved Residues in Active Site and Loop Region Involved in Catalysis and 
Proton Relay System of wgMDH. 
Loop region is highlighted in light green ribbon model. His-Asp dyad shown in purple and pink 
sticks model. Catalytic Arg shown in pink and blue sticks model. Co-factor and substrates shown 
in spheres model. 
Within the active site there are a few conserved residues. A His-Asp (H220 and D193 in 
wgMDH) dyad21 is conserved and is present to act as a proton relay system during catalysis22 
(Fig. 3). It can be seen in Fig. 2 the His-Asp dyad is positioned in close proximity to the substrate 
bound. It is postulated that in the forward direction of the catalyzed reaction, H220 acts as a 
Bronsted-Lowry base in this dyad, removing a proton from malate and transferring it to NAD+ to 
form NADH21. The partial positive charge on the C2 atom of malate assists with the hydride 
transfer from NADH to oxaloacetate22. However, the mechanism of this hydride transfer is 
 5 
unknown. In addition, the role of H220 in the reverse direction of the reaction is also unknown 
and may be different from its role in the forward direction. D193, adjacent to H220, assists in 
catalysis by increasing the basicity of H22021. In addition to the His-Asp dyad, there are three 
catalytic arginines (R124, R130 and R196 in wgMDH) conserved in the active site (Fig. 3). Two 
of which (R124 and R130) are on the loop and the other (R196) is behind the active site23 as seen 
in Fig. 3. These arginines play an important role in substrate binding/specificity and are 
positioned to stabilize and orient substrates for catalysis23. R124 plays an important role in 
substrate specificity via hydrogen bonding to the carboxylate group of oxaloacetate/malate23 and 
R130 assists in both reaction catalysis and substrate binding23. Both R124 and R130 also 
facilitates the closing of the loop when substrate is bound23. R196 completes the triad in which 
its guanidino group coordinates the substrate bound by hydrogen bonding to its carboxyl group23. 
The enzyme-substrate interaction and Arg-carboxylate group of  malate interaction gives the 
stereospecificity for catalysis. However, the specific mechanism to which the catalytic triad 
perform these roles are unknown. From prior studies performed by Bell, it was believed that the 
binding of malate/oxaloacetate in the active site draws the loop in to take on the closed 
conformation22. This closed conformation is thought to be needed for an efficient reaction 
catalysis22. Nevertheless, these hypotheses have not been experimentally confirmed. 
Like other metabolic enzymes, MDH is highly regulated with malate, oxaloacetate and citrate as 
its effectors24. Citrate, one of the products of the TCA cycle, is a known allosteric inhibitor of 
gMDH and has a similar structure to its substrate, oxaloacetate. It binds in and competes for the 
active site. Though it is called an allosteric inhibitor, no studies have found an allosteric site 
distinct from the substrate binding site. When citrate is bound, it reduces NADH binding and 
subsequently reduces enzymatic rate24. As well as allosteric regulation, substrates of MDH also 
regulate enzymatic activity via substrate inhibition. High concentrations of malate stimulates the 
production of oxaloacetate while high concentrations of oxaloacetate inhibits the enzymatic 
reaction24. Previous kinetic studies of mMDH have shown that at high concentrations of 
malate/oxaloacetate, deviations from Michaelis-Menten kinetics were observed25.  
 
FIGURE 4 
Phylogenetic Tree of Cytoplasmic, Archaeal, Mitochondrial MDH and LDH. 






















Because the TCA cycle is utilized by all aerobic organisms’ cellular metabolism, it is essential to 
note the evolutionary aspects of MDH. With regards to energy metabolism, all MDHs are NAD-
dependent except for chloroplast MDH, which requires NADP as a coenzyme rather than 
NAD17. When MDH utilizes NAD/NADH during metabolism, it is involved in degradative 
pathways whereas NADP/NADPH during metabolism is involved in biosynthetic pathways such 
as fatty acid synthesis in the thylakoids26. Based on sequence similarity, Goward and Nicholls 
proposed there was a divergence into two main groups: mitochondrial and cytosolic17 (Fig. 4). 
Phylogenetic studies of different organism’s cytoplasmic, mitochondrial, archaeal MDH and 
LDH have revealed the link between MDH evolution to the endosymbiotic theory27 (Fig. 4). 
Mitochondrial MDH showed a higher sequence similarity to prokaryotic MDH than to 
cytoplasmic MDH, hinting cMDH recently diverging from a common bacterial ancestor14. Other 
x-ray crystal structures of MDH extremophiles and thermophiles have been analyzed28, 
signifying the adaptation of MDH in different environments (Fig. 6A). Thermal stability 
difference between thermophilic and mesophilic MDH is a combination of increase in salt 
bridge, hydrogen bonds, increase interactions in the subunit interface, and packing density in the 
subunits19. But, in general, thermal stability of MDH (gMDH) is stable up to temperatures of 






Structural Alignment of Opened and Closed Conformations of Mobile Loop in MDH and 
LDH. 
(A) Closed conformation (C-subunit of PDB:1SMK) is shown in light blue ribbon. Opened 
conformation (D-subunit of PDB:1SMK) is shown in dark blue ribbon. Citrate is shown as pink 
spheres. (B) Closed conformation (Liganded LDH PDB:1T2D) is shown in dark blue ribbon. 
Opened conformation (Apo LDH PDB:2X81) is shown in light blue ribbon. Co-factor and 
substrate shown as spheres. 
As seen in Fig. 4, MDH has ancestral similarity to other dehydrogenases. Lactate dehydrogenase 
(LDH) is an enzyme involved in metabolism where it converts lactate to pyruvate29 and has 
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similarities to MDH (Fig. 5B). Though LDH is a tetrameric enzyme and MDH is a dimeric 
enzyme, the idea of LDH evolving from MDH has been proposed because of the similarity in 
structures and substrate specificity30. The active site of both LDH and MDH contains the flexible 
loop as well as the conserved His-Asp dyad linked together by a hydrogen bond21 and the three 
catalytic Arg residues. LDH recognizes pyruvate and lactate as its substrates, hinting the 
divergence of LDH from MDH altered the substrate specificity of malate/oxaloacetate to 
lactate/pyruvate30. To gain further insight into the role of the mobile loop, it is essential to 
compare MDH to LDH, as the evolution of LDH from MDH required the enzyme to alter its 
substrate specificity to bind lactate/pyruvate rather than malate/oxaloacetate. In both LDH and 
MDH, the active site contains a mobile loop (Fig. 5). In all MDHs, an Arg residue is present in 
the 124 position where it plays a role in salt bridge formation with carboxylate group of malate 
and OAA. However, in LDH, a Gln residue is present (Fig. 6B). This Gln recognizes the methyl 
group of lactate and pyruvate, its substrates13. Interestingly enough, Gln is an uncharged, polar 
residue whereas Arg is a positively charged residue. A study by Boernke revealed a R124Q 
mutation in E. coli MDH altered substrate specificity in which MDH had an affinity for pyruvate 
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Clustal Omega Sequence Alignment of Various Malate Dehydrogenases and Lactate 
Dehydrogenases. 
(A) Sequence alignment of lactate dehydrogenases. Loop region highlighted in blue box. Position 
125 (based on 1SEV sequence) is highlighted in black box. (B) Sequence alignment of MDH of 
extremophiles: radiophiles, cryophiles, thermophiles and halophiles. Loop region highlighted in 
blue box. Position 125 (based on 1SEV sequence) is highlighted in black box. (C) Sequence 
alignment of Mycobacterium tuberculosis, Plasmodium falciparum, human cytoplasmic and 
mitochondrial MDH. Loop region highlighted in blue box. Position 125 (based on 1SEV sequence) 
is highlighted in black box. (D) Sequence alignment of five species of Mycobacterium tuberculosis 
complex.  
 
With the extensive information known about MDH, the proposed drug design for Mtb will have 
to exploit subtle differences in structure and function between watermelon glyoxysomal MDH, 
the isoform that will undergo site-directed mutagenesis, and M. tuberculosis MDH (tbMDH) due 
to the highly conserved nature of MDH in organisms. Due to the mobile loop’s essential role in 
substrate binding, specificity and catalysis, residues within this loop is the perfect target for 
allosteric inhibitor drugs. In order to target pathogenic bacteria MDH rather than human MDH, 
the residue target of interest within the loop cannot be one of the catalytic Arg, for it will render 
all MDH within the host inactive. In addition, the residue must have a critical role in binding, 
specificity and/or catalysis in order to render the bacterial MDH enzyme inactive. Sequence 
alignment via Clustal Omega was implemented to investigate subtle differences in the conserved 
loop region. The first alignment was done between prokaryotic, NADP dependent, human MDH 
as well as LDH (Fig. 6B). Lys 125 (based on 1SEV sequencing number) is conserved throughout 
except in prokaryotic MDH and LDH (Fig. 6B) as well as certain extremophiles (Fig. 6A). In 
place of Lys, residues present are either Arg, Gln, Thr or Gly (Fig. 6A-B). Interestingly, several 
pathogenic bacterial MDH, such as Mtb, has a Gly in place of Lys, a residue with properties very 
distinct from Lys (Fig. 6C). From this insight, another sequence alignment was done with five 
different species of the M. tuberculosis to determine if Gly at position 125 is truly conserved 
throughout (Fig. 6D). As shown in Fig. 6D, Gly is conserved throughout the species suggesting 








MTuberculosis MDH DGVSLAL GARP G GMERSDLLEA AIFTAQGKALNAVAADDVRVGVTGNPANTNAL 139 
Human_ cMDH KDLDVAI GSMP R GMERKDLLKA IFKSQGAALDKYAKKSVKVIWGNPANTNCL 138 
Pfalciparum_MDH KDADIIV AGVQ K GMTREDLI GV KIMKSVAESVKLHCSK- AFVICVSNPLDIM-- 124 
Human mtMDH KGC DVW K GMTRDDLFNT TIVATLTAACAQHCPE- AMICVIANPVNSTIP 149 
lSEV_ Glyoxysomal_ wgMDH TGMDLII K GMTRDDLFKI GIVKTLCEGI AKCCPR- AIVNLI SNPVNSTVP 169 
.. . . ** *·**: * ** 
M.Canettii CAFPLLSGVEI GSDPQKIFDGVSLAL GMERSDLLEAN AIFTAQGKALNAV 120 
M. Africanum CAFPLLSGVEI GSDPQKIFDGVSLAL GMERSDLLEAN AIFTAQGKALNAV 120 
M.Bovis CAFPLLSGVEI GSDPQKIFDGVSLAL GMERSDLLEAN AIFTAQGKALNAV 120 
M.Microti CAFPLLSGVEI GSDPQKIFDGVSLAL GMERSDLLEAN AIFTAQGKALNAV 120 
M. Tuberculosis CAFPLLSGVEI GSDPQKIFDGVSLAL GMERSDLLEAN AIFTAQGKALNAV 120 
************************** ***** * *********** ************* 
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TABLE 1 
K125 Interactions in Liganded Enzyme (C-Subunit). 
HINT table data illustrating K125 interactions with other nearby residues that occur in the C-
subunit (closed conformation) but absent in the D-subunit (opened conformation). Strength and 
type of interactions are reported. 
 
To further investigate the significance of K125, HINT tables of K125 side-chain interactions at 
minimized energy were analyzed in the liganded subunit (C-subunit) and empty subunit (D-
subunit). Table 1 lists interactions present in the C-subunit but absent in the D-subunit. Most 
interactions were made with the backbone of K125, but only two interactions with G263 and 
P126 were made with the sidechain of K125. Another HINT analysis was performed for the apo 
enzyme (D-subunit) to investigate if there are interesting interactions occurring when 
substrate/co-factor is not bound (Table 2). The only interaction made with K125 sidechain is 
with P126 backbone, suggesting the interaction made with G263 is essential for catalysis and/or 
substrate binding (Table 2). Interestingly, K125 did not seem to show any interactions with R124 
despite the close proximity of the two residues (Fig. 7).  
TABLE 2 
K125 Interactions in Apo Enzyme (D-Subunit). 
HINT table data illustrating K125 interactions in the opened conformation/unliganded subunit with 
other nearby residues. Strength and type of interactions are reported. 
 
K125 Atom 
Residue Interacting Strength of 
Type of Interaction with K125 Interaction 
N M128 CG -11 Hydrophobic/Polar 
N M128 SD 68 Hydrogen Bond 
N M128 CE -41 Hydrophobic/Polar 
0 M128 CB -12 Hydrophobic/Polar 
0 M128 CG -20 Hydrophobic/Polar 
0 M128 SD -22 Base/Base 
0 V258 CG1 -87 Hydrophobic/Polar 
0 V258CG2 -15 Hydrophobic/Polar 
0 0259 OE1 -16 Base/Base 
0 Q259 OE2 -47 Base/Base 
NZ G263O 18 Acid/Base 
CB P126 CD 11 Hydrophobic 
K125 Atom 
Residue/atom Strength of Type of Interaction 
Interacting with K125 Interaction 
0 PRO126 0 -39 Base/Base 
0 PRO126 CB -1 3 Hydrophobic/Polar 
0 PRO126 CG -12 Hydrophobic/Polar 
0 PRO126 CD -19 Hydrophobic/Polar 
0 GLY127N 82 Hydrogen Bond 
0 GLY127 CA -24 Hydrophobic/Polar 
0 GLY127 0 -19 Base/Base 
0 MET128 N 194 Hydrogen Bond 
0 MET1 28 0 -1 1 Base/Base 
0 MET128 CE -62 Hydrophobic/Polar 
CB PRO126 CD 11 Hydrophobic 
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As shown in Fig. 7, both K125 and R124 orients in the same manner when the loop closes and 
opens (Fig. 7). However, K125 points outwards from R124 in the closed and opened 
conformation (Fig. 7). It is important to note the restrictions of the HINT tables since enzymes 
do not function at minimal energy in nature; thus, it may be possible the interactions between 




K125 and R124 Orientations in Opened and Closed Conformations 
Loop region’s conformations are overlaid. Opened conformation (D-subunit) is highlighted in dark 
blue ribbon model. Closed conformation (C-subunit) is highlighted in light blue ribbon model. 
R124 and K125 are highlighted in sticks model. Citrate is shown as spheres. 
 
From the interactions listed in Table 1, in the closed conformation, unfavorable interactions had 
an overall strength of -271 and favorable interactions had an overall strength of 97. In the opened 
conformation, all unfavorable interactions had an overall strength of -478 and favorable 
interactions had an overall strength of 327. In both conformations, there exists much more 
repulsive forces versus attractive forces with regards to K125 interactions. These repulsive 
forces, although unfavorable, are essential for catalysis and enzymatic function; thus, mutating 
K125 may decrease the total amount of unfavorable interactions made with this residue but may 
reduce enzymatic function.  
R124 
Open 





Proposed K125 Interactions with G263 and R124. 
Guanidine group of R124 and amine group of K125 interacts at 14.8 Å distance. Backbone 
oxygen of G263 and amine of K125 interacts at 8.1 Å distance. Residues are shown as sticks 
model. 
 
From the sequence alignments and HINT table analysis, it is hypothesized that the role of K125 
may involve the positioning of R124 via charge repulsion and a stabilizing hydrogen bond with 
G263 to guide the substrate into the active site, thus completing the electrostatic pre-organization 
required for catalysis. As seen in Fig. 8, G263 is 8.1 Å away from the nitrogen of K125 and 
nitrogen of R124 is 14.8 Å away. Because of this close proximity, we hypothesize the nitrogen 
of K125 and oxygen of G263 may be working simultaneously to hold R124 in a specific 
orientation that will allow for efficient catalysis. Interestingly, the charge-charge contact between 
K125 and R124 seems to be working together to coordinate the substrate, malate. R124 charged 
guanidino group interacts with the negatively charged oxygen of malate and K125 charged side-
chain interacts with R124 charged side-chain via charge-charge repulsion. This repulsion 
between R124 and K124 may be assisting the coordination of the substrate in the binding pocket 
which in turn also coordinates the co-factor binding for efficient catalysis. 
 
FIGURE 9 
Proposed Mutations of K125 – K125A and K125R. 
(A) K125A and (B) K125R shown as white sticks model. R124 and G263 shown as blue sticks 







To investigate the proposed interactions between R124, G263 and K125, we propose two 
mutations: K125A and K125R (Fig. 9). K125A is of interest because of the Gly conserved 
residue at the 125 position in place of Lys observed in M. tuberculosis MDH (Fig. 6C). Although 
Ala contains an extra methyl group compared to Gly, it is similar in size to Gly and mutating an 
Ala instead of Gly will decrease the chances of drastically altering the protein’s backbone 
structure. By removing the Lys and mutating it to Ala, size of residue and charge is altered and is 
predicted to drastically change binding, specificity and catalysis (Fig. 9A). K125A will lose the 
hydrogen bond between G263 as well as the charge-charge repulsion with R124. In addition, 
K125R is proposed as another mutation in order to preserve the size and charge of Lys and is 
predicted to exhibit similar activity and role as K125 (Fig. 9B). K125R and R124 are 10.3 Å 
away from each other, a closer distance compared to K125 and R124. However, there is a bigger 
distance between the nitrogen of K125R and the oxygen of G263, compared to the nitrogen of 
K125. 
To test the hypothesis regarding K125, we propose several experiments (Table 3). Specific 
activity will be performed in order to determine kinetic parameters of both mutants to analyze 
each mutants’ catalytic efficiency compared to native (Table 3). NADH varied kinetics will be 
done in order to analyze each mutants’ ability to bind co-factor NADH. Km and Vmax will be 
compared to native’s published values as well as experimental values. Oxaloacetate (OAA) 
varied kinetics will be done to analyze each mutants’ ability to bind substrate. Km and Vmax will 
be compared to native’s published values as well as experimental values. Thermal stability and 
binding abilities of both mutants will be studied by obtaining each mutant’s Tm and comparing it 
to native values via Fluorescence based Thermal Shift assays (FbTSA). Last but not least, 
inhibition kinetics with malonate, pyruvate and citrate will be performed to test substrate 
specificity of each mutant. If there is evidence the MDH mutants bind pyruvate like LDH, the Ki 
for pyruvate will decrease. 
TABLE 3 
Predictions of Observations for K125A and K125R. 
Observations that may support or falsify our hypothesis are reported for all experiments that will 
be done. 







Specific Activity No change ↓ / ↑ Vmax ↓Vmax ↑Vmax/no change 
NADH Varied No change ↓ / ↑ Km ↑Km ↓ Km/no change 
OAA Varied No change ↓ / ↑ Km ↑ Km ↓ Km/no change 
FbTSA Stability No change ↓ / ↑ Tm ↓ Tm ↓ Tm/no change 
FbTSA Binding No change in saturation curve 
Change 
in saturation curve 
No saturation 
curve 
No change in 
saturation curve 
Inhibition Kinetics  No change ↓ or ↑ Ki ↑ Ki ↓ Ki/no change 
 
Table 3 highlights the predictions made for both mutants regarding the experiments that will be 
performed. As mentioned, K125R is expected to have similar activity to native (K125). Because 
K125R will experimentally be similar to native, Km and Vmax for oxaloacetate and NADH, Tm 
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and substrate specificity will be similar to native values (Table 3). In contrast, K125A is 
predicted to significantly alter enzymatic function and activity compared to native. Km will 
increase for oxaloacetate and NADH, Vmax will decrease, increase in Ki for inhibitors malonate, 
pyruvate and citrate, as well as decrease in Tm due to the absence of charge and decrease in 
residue size (Table 3).  
If our hypothesis is true, K125R will perform similarly to native wgMDH and K125A will 
decrease enzymatic function and stability – supporting the importance of the charge-charge 
repulsion between R214 to keep this residue in the correct orientation for efficient catalysis. If 
our hypothesis is incorrect, K125R and K125A does not alter enzymatic activity and stability – 
falsifying the importance and critical role of the interactions between R124 and K125. In turn, if 
both mutants decreased the activity compared to native, the point charge of Lys may be critical 
for efficient catalysis as opposed to the resonance-based charge of Arg. These experiments 
combine will give insight into the role of K125 in catalysis, binding, stability, regulation and 
substrate specificity. Overall, if these studies support the interaction between R124 and K125, 
K125 may be the key residue that may be targeted for allosteric inhibitor drug design. By 
designing a multifaceted drug inhibitor for the loop region of MDH, this may render the 




PyMOL Analysis – The structure of wgMDH (1SMK)32 was downloaded from the protein 
database (PDB). All molecular graphics were completed in PyMOL33. 
Multiple Sequence Alignment - MDH and LDH sequences of various eukaryotic and 
prokaryotic species were obtained via the PubMed protein database. Once sequences were 
acquired, Clustal Omega was used to align the various sequences and exploit conserved residues 
between each species. Residues of interest were chosen in the active loop site, which is position 
119-134 based on 1SEV sequence34.  
HINT Tables Analysis – High-quality Protein Interactomes (HINT) tables provide binary and 
co-complex protein-protein interactions which highlight the types of interactions occurring 
between residues of interest35. HINT tables of residue K125 interactions in the C subunit and D 
subunit were obtained in order to explore the various attractive and/or repulsive interactions the 
residue of interest has with other nearby residues.  
Site-Directed Mutagenesis, Expression, and Purification – The QuikChange Lightning Site-
Directed Mutagenesis Kit47 was used to create desired single-amino acid substitutions within 
wgMDH36. Primers for K125A and K125R were ordered: 
K125A: 5’-GCAGGTGTTCCTCGAGCCCCAGGAATGACGAGG-3’ 
K125R: 5'-CCCTGCAGGTGTTCCTCGAAGGCCAGGAATGACGAG-3' 
Mutations were confirmed via DNA sequencing following purification using QIAprep-Miniprep 
Spin Kit37. Miniprep kit yielded 61.8 ng/µL of K125R and 5.8 ng/µL of K125A purified DNA 
solution. Transformed bacteria were expressed in LB media, induced with 2 mL of IPTG and 
after 5 hours were harvested and collected by centrifugation. Cells were frozen in -80°C. Mutant 
MDH Ni-NTA affinity46 chromatography was completed as per the QIAexpressionist 
protocol32,38. To ensure that all unwanted protein was removed, the wash was monitored using 
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bradford reagent. Elution fractions were monitored using bradford reagent to determine relative 
mutant protein concentrations.  
SDS-PAGE and Bradford Assay – To determine the concentrations of mutant protein elutions, 
Bradford Brilliant Blue Assay was utilized39. A standard curve was constructed using 0–10 µg of 
Bovine Serum Albumin (BSA) at 1 mg/mL in order to calculate mutant elution concentrations. 
SDS-PAGE gel electrophoresis was performed to confirm the expressed protein was at the right 
molecular weight of wgMDH (34 kDa)40. SeeBlue™ Pre-stained Protein Standard ladder was 
utilized to monitor protein electrophoresis. 
Experiments 
Kinetics General Method – Kinetic parameters, citrate inhibition, and pyruvate reduction were 
determined for native wgMDH, along with the K125A and K125R mutants. The buffer, NADH, 
and Milli-Q water (and citrate or pyruvate for the indicated experiments) were premixed in 
triplicate. OAA and enzyme (diluted to produce a linear rate) were added immediately before the 
run, mixed with a transfer pipette, and then immediately began scanning for 30 seconds (or 10 
minutes for pyruvate reduction) using a UV-Vis spectrophotometer. All kinetic assays were 
performed by measuring the oxidation of NADH to NAD+ at 340 nm (NADH absorption vs. 
time).  
Specific Activity Assay – Specific activity assays were performed to determine the overall 
catalytic efficiency of the mutants compared to native wgMDH. Each specific activity assay 
mixture contained 0.05 M Phosphate Buffer (pH 8), 100 μM NADH, 200 μM OAA, and 10 μL 
of 1.42 mg/mL of K125R, 4.08 mg/mL of K125A or 1 mg/mL of native wgMDH. This was 
repeated 5 times for each enzyme.  
NADH Varied and OAA Varied Assays – To determine substrate binding of mutants compared 
to native, OAA varied kinetics was ran between 25 μM to 2 mM (8 concentrations) at fixed 200 
μM NADH, 0.05 M Phosphate Buffer (pH 8), and 10 μL of enzyme. To determine cofactor 
binding of mutants compared to WT, NADH varied kinetics was ran between 25 μM to 200 μM 
(8 concentrations) at fixed 250 μM OAA, 0.05 M Phosphate Buffer (pH 8), and 10 μL of 1.42 
mg/mL of K125R, 4.08 mg/mL of K125A or 1 mg/mL of native wgMDH. Each concentration 
(for NADH and OAA that was varied) was repeated in triplicate. 
Citrate Inhibition Assay – To understand how the mutant’s change in structure affected the 
ability of citrate to regulate enzymatic activity, citrate inhibition assays were performed. Each 
citrate inhibition assay mixture contained 100 μM NADH, 500 μM OAA, varying 0 mM – 20 
mM citrate, 0.05 M Phosphate Buffer (pH 8), and 10 μL of 1.42 mg/mL of K125R, 4.08 mg/mL 
of K125A or 1 mg/mL of native wgMDH. Each varying concentration of citrate was repeated in 
triplicate. 
Pyruvate Reduction Assay – To understand substrate specificity and catalysis of mutants of 
interest in comparison to LDH, kinetic parameters for native and mutant wgMDH were 
determined. The reagents in each assay include fixed concentrations of 200 mM NADH, 0.05 M 
phosphate buffer, and 100 µL of 1.42 mg/mL of K125R, 4.08 mg/mL of K125A or 1 mg/mL of 
native wgMDH. Each reaction was carried out with 0 and 40 mM of sodium pyruvate. Because 
pyruvate has been known to decrease MDH activity by at least 6-folds34, each reaction was 
allowed to run for 10 minutes. Triplicates of each pyruvate concentration were carried out for 
native and mutant wgMDH.  
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Inhibition Assay – To determine whether mutations may have impacted the binding site 
specificity for 3 carbon (pyruvate, malonate) or 6 carbon (citrate) compounds, kinetic parameters 
were determined when pyruvate, malonate or citrate were used as inhibitors. Each inhibitor assay 
mixture contained 100 μM NADH, 500 μM OAA, varying 0 – 20 mM of inhibitor of interest, 
0.05 M phosphate buffer (pH 8), and 10 μL of 1.42 mg/mL of K125R, 4.08 mg/mL of K125A or 
1 mg/mL of native wgMDH. Assays were repeated in triplicate and performed for each inhibitor. 
Fluorescence Based Thermal Shift Assay – FbTSA was performed in a 96 PCR well plate using 
a Bio-Rad CFX96 Real-Time System to assess protein stability. Thermal shift scans were 
performed over a temperature range of 10℃ - 95℃ in 0.5°C/min increments with fluorescence 
detection every 30 seconds. Well plates contained 200X Sypro Orange in DMSO, 4 µM enzyme 
(K125A, K125R, or native wgMDH), 0.05 M phosphate buffer, varied amounts of NADH (1 
mM or 5 mM) or citrate (100 µM and 500 µM) and MilliQ water. Ligand concentrations were 
varied for each mutant and native wgMDH. Data was background corrected via negative control 
(buffer and SYPRO orange).  
 
Analysis and Potential Outcomes 
Kinetics Assay Analysis – The slopes of absorbance at 340nm (NADH absorption vs. time) gave 
determination of the rate of the reaction. Rates were used will be used to produce plots of rate 
versus concentration of NADH or OAA (to give KmNADH,OAA and Vmax or at fixed NADH and 
OAA concentrations with varied citrate concentrations to give KiCitrate and Imax, the maximum 
extent of citrate inhibition or varied concentrations of pyruvate to determine the Km for pyruvate. 
For specific activity, the enzymatic activity (average change Abs/min) was divided by the 
concentration of protein (in mg/mL). For all assays, the protein concentration used to calculate 
parameters was determined by Bradford Assay as described above. All of the varying 
concentration assays were described by a saturation function43 which were analyzed using a least 
squares fitting routine44 to the equation Observation = Amax[L]/(B + [L]) where Amax was the 
maximum value of the observed phenomenon (Vmax, Imax, etc.), B was Km or KiCitrate depending 
upon the experiment, and L was the concentration of the varied ligand (NADH, OAA, Citrate, 
Pyruvate, etc.). This allowed the appropriate parameter to be determined, +/- its standard 
deviation. Statistics were used to compare these values from native and mutants, allowing the 
significance of any changes in functionality to be determined.  
FTS Analysis – Based on the thermal melting temperatures, it will be determined as to whether 
stability is comparable between the native and the K125A and K125R mutants. The change in 
fluorescence as temperature changes is averaged from triplicate trials. The first derivative of the 
change in fluorescence is calculated and the temperature of the maximum of the derivative is 
determined. The change in melting temperature from the triplicate trials were averaged. Data was 
corrected using negative controls and curve-fitted via SigmaPlot44 to determine the melting 
point.  
Potential Outcomes – Observed changes only in Vmax would suggest K125 is critical for 
catalytic turnover, changes in Km or KD would indicate a role in loop movement to close the 
active site and hold the substrate/product in place, while changes in both would suggest a dual 
role for K125 in loop movement. Changes in KiCitrate or Imax would indicate a role in ligand 
discrimination. Activity observed with pyruvate as a substrate would suggest the lack of 
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substrate specificity when K125 is mutated and the importance of this residue for OAA/Malate 
specificity. Changes in Tm could indicate that K125 has a role in thermal stability. 
RESULTS 
Plasmid Construction and Purification of K125 Mutants. Primers were designed for mutants 
K125A and K125R of wgMDH.  
K125A: 5’-GCAGGTGTTCCTCGAGCCCCAGGAATGACGAGG-3’ 
K125R: 5'-CCCTGCAGGTGTTCCTCGAAGGCCAGGAATGACGAG-3').  
QuikChange Lightning Site-Directed Mutagenesis protocol was utilized in order to introduce and 
express the point mutations into pQE60 plasmid. WgMDH mutants were purified via Ni-NTA 
affinity chromatography and each mutant was purified and eluted in two batches (“A” and “B”). 
SDS-PAGE gel indicated the presence of the protein via the presence of a significant band at 
approximately 34 kDa and the absence of miscellaneous impurity bands for both mutants and its 







SDS-PAGE of Purified Native and Mutants K125A and K125R. 
A) Coomassie stained SDS-PAGE gel of K125R (A) and K125R (B) elution fractions 1-5 and flow 
through samples. B) Coomassie stained SDS-PAGE gel of K125A (1) and K125A (2) elution 
fractions 1-5 and flow through samples. 
 
Significant K125 Interactions Investigated in Binary and Ternary Complex via HINT 
Analysis. High-quality Protein Interactomes (HINT) analyses were done for both binary and 
ternary complexes of wgMDH. It is essential to note that HINT analysis is a modeling system 
and assumes MDH structure is energy minimized. Therefore, HINT does not take into account 
how MDH exists in vivo; however, it is still an essential tool in garnering information regarding 
potential, existing interactions within MDH. With that said, HINT tables showed favorable 
K125R " A-








interactions between K125 and co-factor NADH in the ternary complex as well as the binary 
(NAD/enzyme) complex (Table 4). Table 4 highlighted a few favorable interactions – 
specifically hydrogen bonding – discovered between the residue and NADH with large 
magnitudes (>400), however there were other similar hydrogen bonding occurring between the 
two molecules. From the HINT tables, it indicated that the ζ-nitrogen of K125 shared three 
different interactions with the co-factor’s phosphate group (O1A, O2A and AP) near the adenine 
ring (Fig. 11). In addition to interactions with co-factor, K125 interacts with substrate malate as 
well via acid/base interaction and strength magnitude of 19 (Table 4). Comparing the binary and 
ternary complex, the strength of K125 interactions with NADH were relatively similar to one 
another (Table 4). From previous HINT analysis of the apo form (unliganded), it’s been observed 
that K125 amine nitrogen makes three different interactions with M128 with a strength of < 60. 
HINT analysis of the D-subunit of wgMDH (no co-factor or substrate bound) has also shown 
terminal nitrogen of K125 interacting with G263 in an acid/base interaction of < 10-20. 
Comparing the three complexes, the interactions made in both the binary and ternary complex 
were much higher than those observed in the unliganded form. 
TABLE 4 
HINT Model – Most Significant Interactions of K125 in the Binary and Ternary Complex.  
HINT model interactions that shows the strongest interactions in the binary and ternary complex. 





PyMOL Model of Significant Interactions Between K125, malate, and NAD+.  
K125 residue shown in white stick figures, malate shown in pink, and NAD+ in orange. 
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Enzymatic Activity Impacted by K125A and K125R. Specific activity assays were done in 
order to determine the effects of the mutations to enzymatic activity. Two trials of specific 
activity assays, done in triplicates for each trial, were done and the activity of mutants and native 
was averaged (Table 5). The % activity of both mutants were calculated and compared to native 
activity, which is reported as 100% activity. As seen in Table 5, mutant K125A and K125R 
activities decreased ≥ 25 folds compared to native wgMDH, which is ≥ 95% activity decrease 
(Table 5, Fig. 12).  
TABLE 5 
Specific activity of wgMDH native and mutants.  
Elution 2 of K125A and K125R was analyzed. 0.05 M sodium phosphate buffer (pH 8) was used 
as dilutant. Fixed concentrations of 100 µM of oxaloacetic acid and 200 µM of reduced 
nicotinamide adenine dinucleotide (NADH) were used in each assay. The activity, reported in %, 





Specific activity of wgMDH native and mutants K125A and K125R. 
Native and mutants specific activity (min-1) were obtained. Triplicate trials of each mutant and 




Average Activity of Native 
min-1:t: SD % 
Native 34391± 538 100 
K125R 665 ± 100 2 
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Mutants Did Not Alter Km But Affected Vmax  of Co-factor and Substrate. Co-factor binding 
was assessed for each mutant via NADH varied kinetics (Fig. 13). For K125A, the Michaelis-
Menten plot of NADH as the varied substrate gave initial kinetic parameters for Km and Vmax as 
130 µM and 1911 µmol/min/µg, respectively (Table 6). For K125R, initial kinetic parameters for 
Km and Vmax was given as 98 µM and 1008 µmol/min/µg, respectively (Table 6). Both mutants’ 
parameters were distinctive from the native, which had Km and Vmax parameters of 71 µM and 
138969 µmol/min/µg, respectively (Table 6). K125A and K125R both increased Km however 
because values are within two standard deviations from the native values, it is not statistically 
different from the native. Vmax of mutants decreased approximately 90 folds (Table 6). In 
addition, substrate binding was assessed for each mutant via OAA varied kinetics (Fig. 14). 
Points were not a good fit for Michaelis-Menten equation due to substrate inhibition exhibited by 
high concentrations of OAA (Figure 14 A-C). For K125A, the Michaelis-Menten plot of 
oxaloacetate (OAA) as the varied substrate gave initial kinetic parameters for Km and Vmax as 35 
µM and 1065.8 µmol/min/µg, respectively (Table 6). For K125R, initial kinetic parameters for 
Km and Vmax was given as 80 µM and 539.6 µmol/min/µg, respectively (Table 6). Native 
wgMDH gave Km and Vmax parameters of 51 µM and 3522 µmol/min/µg, respectively (Table 6). 
Parameters were different from native values, where K125A decreased Km and K125R increased 
Km. But like NADH varied kinetics results, because values are within two standard deviations 
from the native values, it is not statistically different from the native. Vmax of mutants decreased 
approximately 2 folds (Table 6). 
TABLE 6 
Kinetics analysis of wgMDH mutants K125A and K125R. 
25-2000 µM OAA and 100 µM NADH were used in the assay for analyzing the Km of OAA. 25-
200 µM NADH and 250 mM OAA were used in the assay for analyzing the Km of NADH. Vmax 







Enzyme NADH OAA 
Km Vmax Km Vmax 
µM µmollminlµg µM µmollminlµg 
Native 71 ± 16 138969 ± 11882 51 ± 24 3522 ± 314 
K125A 130 ± 26 1911±231 35 ± 12 1065.8 ± 66 













Michaelis-Menten Plots of NADH Varied Assays of Native, K125A and K125R. 
NADH varied kinetics on wgMDH native (A) and mutants K125A (B) and K125R (C) at fixed 
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FIGURE 14 
Michaelis-Menten Plots of OAA Varied Assays of Native, K125A and K125R. 
OAA varied kinetics on wgMDH native (A) and mutants K125A (B) and K125R (C) at fixed 100 
µM NADH and 50 mM phosphate buffer at pH 8. 
Substrate Specificity Altered in K125 Mutants. Substrate inhibition kinetics assays were 
performed in order to determine the impact of K125 mutations on the binding site specificity for 
3 carbon (pyruvate and malonate) and 6 carbon (citrate) compounds. For those that exhibited 
substrate inhibition, the change in activity was calculated and plotted against concentration of 
substrate in order to determine Ki. Native wgMDH exhibited substrate inhibition by only citrate 
and had Ki of 4.95 µM (Fig. 15D). K125A showed no substrate inhibition (Fig. 15B,E). 
Specificity for citrate was altered when compared to native. Contrastingly, K125R was substrate 
inhibited by both malonate and citrate, with Ki of 57 µM and 0.97 µM, respectively (Fig. 15C,F). 
Compared to native, the mutant impacted binding site specificity. K125R had a higher affinity 














































































Inhibition Kinetics of Native, K125R, K125A with Malonate and Citrate 
Inhibition kinetics on native wgMDH, K125R and K125A mutants with varying concentrations of 
citrate and malonate and fixed 100 μM NADH, 500 μM OAA, and 50 mM Phosphate Buffer (pH 
8). Ki was calculated for those that appeared to show inhibition. (A) Native with varying 
[malonate]. (B) K125A with varying [malonate]. (C) K125R with varying [malonate]. (D) Native 
with varying [citrate]. (E) K125A with varying [citrate]. (F) K125R with varying [citrate]. 
K125 Mutants Impacted Stability of wgMDH. Thermal melt curves were obtained from 
FbTSA for the native and mutants (Fig. 16) In general, the more stable the protein is, the higher 
the Tm, vice versa. At maximum fluorescence, the melting temperature (Tm) for both mutants and 
native increased as NADH concentrations increased (Table 7). The stability of the protein was 
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NADH was added, native exhibited the lowest Tm and K125 had the highest (Fig. 16B, 7D). 
Interestingly, at 500 μM K125R exhibited the highest Tm with native Tm still at the lowest (Fig. 
16F). The discrepancies in fluorescence values were due to inconsistent protein concentrations 
and/or SYPRO orange dye concentrations. 
FIGURE 16 
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Melt curves of native (A,B), K125A (C,D) and K125R (E,F) were graphed from 35 – 55 °C. NADH 
concentrations were varied at 0,100 and 500 μM varied with fixed enzyme concentration of 4 μM. 
Melting temperatures were calculated by finding the maximum fluorescence at a specific 
temperature (°C) and averaged the triplicate trials. 
 
TABLE 7 
Summary of Melting Temperatures (Tm) of Native and Mutants. 
Tm is reported as °C ± standard deviation (SD) at NADH concentrations of 0, 100 and 500 μM. 
 
 
Decreased Co-factor Binding in K125 Mutant. The change in Tm was calculated from FbTSA 
melt curves for native wgMDH and mutants. Two FbTSA assays were performed on the samples 
with varied NADH concentrations, where the first trial included only three varied concentrations 
of NADH and the second trial varied six concentrations of NADH (Fig. 17). In the first trial, the 
aim was to determine if there is a change in Tm when co-factor concentrations were varied. 
There was an indication that there is a change in Tm for native and both mutants, therefore 
another trial of FbTSA will be done. A second trial was conducted in order to analyze NADH 
binding’s effects on mutants’ Tm with more varied concentrations of NADH. Interestingly, in 
the second trial, native and K125R ∆TM values were curve-fitted via Michaelis-Menten equation 
but K125A did not fit the curve (Fig. 17). Because the saturation curve can be observed for 
native and K125R, this corresponds to the HINT table analysis (Table 4) where native and 
K125R interacted with NADH but K125A lost this interaction. However, due to the large errors 
and poor Michaelis-Menten curve fits, additional trials of FbTSA must be done.  
In addition, the change in Tm from 0 μM to 100 μM and 500 μM NADH for native and mutants 
suggest the same results. In general, Tm increases when co-factor is bound and Tm does not 
change when co-factor isn’t bound. At 500 μM, K125R exhibited the highest change in Tm while 
K125A exhibited the lowest change in Tm compared to native (Table 8). Although K125A had 
the lowest change in Tm, the change is only 0.3 °C away from native’s Tm (Table 8). This 
suggests K125A weakly binds NADH while K125R strongly binds NADH. 
Enzyme Tm 
0µM 100µM 500µM 
°C:t:SD °C:t:SD °C:t:SD 
Native 44.3 ±0.288 44.8 ±0.288 45.8 ±0.288 
K1 25A 46.5 ± 0 47 ±0 47.7 ±0.288 




∆TM Curves of Native and Mutants. 
The change in melting temperature (∆TM) was reported for native (black), K125R (red) and 




Summary of Change in Melting Temperatures of Native and Mutants at 0 and 500 μM. 
Tm is reported as °C at NADH concentrations of 0, 100 and 500 μM. Tm at 0 μM was subtracted 




K125 Mutants Increased Stability of wgMDH. From the melting curves via FbTSA, the increase 
in Tm of both K125 mutants compared to WT wgMDH suggest K125A and K125R increased the 
stability of the enzyme. This result suggest that residue K125 exhibits unfavorable interactions 
within native wgMDH and by mutating this residue to an Arg and Ala, this interaction is no 
longer present; thus, stabilizing the structure further. Although the interactions K125 makes with 
nearby residues are potentially unfavorable, it is nonetheless essential for catalysis. For example, 
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may be unfavorably interacting with nearby hydrophobic residues within the loop such as V122 
(Fig. 18). When mutated to K125A, this unfavorable interaction is no longer present. 
 
FIGURE 18 
K125 Proposed Interaction. 
V122 and K125 proposed hydrophobic/polar unfavorable interaction. Residues are 6.3 Å apart. 
 
The increase in stability observed in the mutants suggest these mutant residues may be producing 
other favorable interactions with nearby residues. Paticularly for K125R, its resonance based 
charge is highly interactive with nearby carboxyl groups. For K125R, the NH2 group of Arg may 
be hydrogen bonding to a nearby carboxyl group of an Asp to create a salt bridge (Fig. 19). D132 
is 8.4 Å away from R125 and these residues may be interacting and creating a salt bridge, which 
explains the increase in structural stability (Fig. 19). 
 
FIGURE 19 
R125 Proposed Interaction. 
D152 and R125 proposed salt-bridge interaction. Residues are 8.4 Å apart. 
 
To explore this proposed interaction, site-directed mutagenesis on D132 is proposed in order to 
observe if the removal of carboxyl sidechain of D132 will affect thermal stability of K125R 
wgMDH mutant. If similar Tm is observed in K125R when D132 is also mutated, this salt bridge 
may not be the cause of the increase in stability in K125R. Nonetheless, further analysis via 
circular dichroism thermal melts must be performed in order to confirm these results. 
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K125 Mutants Significantly Decreased Catalytic Efficiency. Specific activities of native, K125A 
and K125R were obtained. Compared to native wgMDH, both mutants exhibited approximately 
98% decrease in activity. These results suggest that the point charge of Lys is an important 
component in catalysis since this point charge is absent in K125A. It is important to note that 
although K125R does not have a point charge and has a resonance-stabilized charge instead, this 
may not be the primary reason why there is significant decrease in catalytic efficiency. A 
positive charge, whether it is a point or resonance stabilized charge, will still interact with 
another negative charge. We postulate there is another reason why K125R activity was 
significantly affected. One explanation for the loss of activity may be due to the change in 
torsional angles of the introduced charge of R125 (Fig. 20). The charge is 2.1 Å away when 
K125 is mutated to R125 (Fig. 20). 
 
FIGURE 20 
K125 and R125 Positioning in Loop Region.  
K125 and R125 are 2.1 Å away. 
 
Another explanation for observed decrease in activity may be due to the nature of Arg and 
introducing this specific residue to the loop. With this mutation, we are essentially creating R125 
closely distanced to R214, a conserved residue known to be involved in substrate specificity and 
correct orientation of substrate. The introduced Arg may be disrupting the role of R124 in 
substrate specificity because of the identical guanidine group being introduced so closely to 
R124 and cause an incorrect orientation of the substrate in the active site. To test this hypothesis, 
another site-directed mutagenesis is proposed for K125 to discern if the same results will be 
observed for other mutants. 
K125 Does Not Play a Role in Substrate/Co-factor Binding. As observed in the NADH varied 
kinetic assays, both mutants K125A and K125R exhibited similar Km compared to native, 
contrary to what was hypothesized and what the HINT tables suggested. Although FbTSA results 
suggest the loss of co-factor binding in K125A, the large errors of the ∆Tm points led to a poor 
Michaelis-Menten curve fit; thus, these results cannot be used to determine any definite 
conclusion. Furthermore, because enzymes are dynamic in nature and are living entities, the 
strong, favorable interactions between K125 and NADH seen in the HINT data of the ternary 
complex is not enough to conclude the residue’s role in binding since it is just an energy-
minimized model of wgMDH. However, we postulate the Km values of both mutants are not 
affected by the mutations due to a change in in Kcat values since Km takes this into account. In 
-.:.·•· 
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order to test this hypothesis, we propose equilibrium dialysis to be performed on the mutants to 
obtain true Kon and Koff values and determine is Kcat is truly affected.  
K125 May Be Involved in Substrate Specificity. Substrate inhibition was performed on both 
mutants and native wgMDH and suggest that K125 may be playing a role in substrate specificity. 
Because K125A was not inhibited by citrate and K125R was inhibited by malonate, this suggest 
that there was a change in substrate specificity as compared to native wgMDH. Nevertheless, 
because of the poor Michaelis-Menten curve fit for both mutants’ inhibition data, this experiment 
will be repeated in order to conclude K125 is truly involved in substrate specificity. We propose 
another mutant, K125Q, in order to confirm these conclusions due to the Gln residue found in 
LDH in position 125 (Fig. 6B). 
In summary, we have revealed through kinetics analysis, stability reports as well as inhibition 
studies that K125 has a significant role in wgMDH overall structure and function. This residue is 
involved in the overall stability and catalysis of wgMDH and may play a role in substrate 
specificity. Further investigation into MDH’s structure and function will uncover distinct 
residues that can potentially be targeted for allosteric drugs, in addition to K125.  
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 The main focus of my research paper is the protein watermelon glyoxysomal malate 
dehydrogenase (wgMDH) and its active site loop’s role in enzymatic function, substrate 
specificity and binding. From previous studies, it was determined that a dynamic loop present in 
the active site and several nearby residues were essential for substrate binding and specificity, 
conformational changes, and effective catalysis. To further investigate this loop region, I utilized 
PubMed, a database I discovered on the Copley Library resources link under the Nursing & 
Health Sciences subject category. PudMed was my most used database during my research due 
to its reliability, plethora of scholarly resources and its protein archives. Using PubMed, I 
obtained FASTA sequences of wgMDH from different organisms (eukaryotes and prokaryotes). 
These sequences were aligned on ClustalOmega and I found that the residue Lysine 125 (K125) 
was conserved in most eukaryotes but not in some bacteria MDH. From the sequence 
alignments, I narrowed my focus on K125, knowing that I wanted to base my research and 
hypothesis on this residue. 
 To confirm the residue’s potential roles in enzymatic function, I utilized HINT tables 
(High-quality protein interactomes) to observe its impact on other nearby residues as well as 
PyMOL, a molecular visualization program. I also wanted to gather primary literature that 
discussed previous work on gMDH. Initially, I explored the Chemistry, Physics & Mathematics 
subject category on the Copley Library website to find databases with primary literature about 
MDH. I found the databases JSTOR and Wiley Interscience Journals and began to search for 
papers with the keyword “Malate Dehydrogenase” in it to familiarize myself with the known 
mechanism and evolutionary aspects of MDH that may help with my hypothesis development. 
 I read the abstract and introduction to each paper I found in order to determine whether 
they were relevant to my own research, and if so, whether I would be able to use their data and 
analysis myself. Once I gathered 10 relevant primary literature sources, I began to write the 
introduction of my paper. About 2 pages in, I realized that in order to write a solid introduction, I 
would need more primary sources. I knew that utilizing my previous methodology of finding 
literature could waste a lot of time because abstracts and introductions take some time to read. 
Needing a more efficient way of determining the value of a paper, I began to narrow down my 
searches on Wiley Interscience Journals and JSTOR to the names of scientists I knew who 
previously worked on MDH, such as L. J. Banaszak, B. Cox, and J. J. Birktoft, and retrieved 
papers they had written about MDH. This shortened my search time for papers because I knew 
these papers would be relevant to my research and would be trustworthy due to the amount of 
authors referencing others of the authors' works. 
 One problem I came across with the JSTOR and Wiley databases was the lack of access I 
had to certain journals that required a rental and purchase fee. I therefore went on PubMed and 
began to search specific keywords such as “dynamic loop MDH” and “b-factors MDH” to find 
resources that correlate to the information I wanted to include in my introduction. Due to 
PubMed’s ease of searching, I committed to using just the PubMed database to find my literature 
for the rest of my introduction. Using PubMed, I gathered about 19 additional papers in the span 
of a week versus the 10 papers I had so far found on JSTOR and Wiley databases combined. 
After analyzing up to thirty journals and writing half of my introduction, I refined my hypothesis 
on the basis of what I had found through my sequence alignments and the papers I had read. I 
knew that my hypothesis would contribute to novel discoveries due to the lack of publishable 
 33 
data and information on K125. K125A and K125R are the 2 mutants I have designed for this 
experiment in order to explore K125’s role in wgMDH. 
 Once I was ready to organize the necessary experiments to prove or falsify my 
hypothesis, I utilized my primary sources once more, this time focusing on the methods sections 
of papers who also utilized site-directed mutagenesis as their method of probing MDH. Most of 
the papers I gathered used similar techniques to those that I wanted use. This process made me 
realize that I could discover potential methodologies by looking at the sources used in the papers 
I was already reading. I utilized sources from 2 different papers to write the preparatory 
experimental methods without needing to sift through PubMed or other databases for new 
papers. This was especially useful when designing the pyruvate reduction assay, because this 
was a technique new to gMDH, and which even our professor had not done in quite some time. 
 For all other assays and protein purification methods, I searched for published protocols 
on company websites such as Qiagen and Agilent technologies for their recommended 
conditions. Once I had written the experiment protocols, I performed the experiments over the 
next few months. I gathered and analyzed data for the results section of my paper. Using 
information I had gathered from primary literature and experimental results, my hypothesis was 
falsified – however, I proposed new hypotheses from my findings for future studies in the 
discussion section of my paper. Overall, my paper utilized 47 sources and the Copley Library 
databases served as a great tool in my search for scientific literature. 
